NasdaqGS - Delayed Quote USD
Anavex Life Sciences Corp. (AVXL)
At close: November 7 at 4:00 PM EST
After hours: 7:59 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| DONHAUSER PETER D.O. Director | Purchase | Jun 14, 2024 | 5,000 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Sale | Mar 28, 2024 | 1,250,210 |
| THOMAS STEFFEN PHD Director | Purchase | May 15, 2024 | 5,000 |
Related Tickers
SAVA Cassava Sciences, Inc.
25.34
-4.63%
ANVS Annovis Bio, Inc.
8.61
+0.35%
LXRX Lexicon Pharmaceuticals, Inc.
1.3000
+7.44%
ATHA Athira Pharma, Inc.
0.7500
+7.14%
MDGL Madrigal Pharmaceuticals, Inc.
354.85
+4.92%
TGTX TG Therapeutics, Inc.
27.90
+2.69%
ARDX Ardelyx, Inc.
6.38
-1.69%
TOVX Theriva Biologics, Inc.
2.1600
+9.64%
ZVSA ZyVersa Therapeutics, Inc.
1.5200
-1.30%
HALO Halozyme Therapeutics, Inc.
59.65
-1.62%